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 
Abstract— This paper presents the methodology used in 
patient-specific calibration of a novel highly integrated model 
of the cardiovascular and pulmonary pathophysiology 
associated with Acute Respiratory Distress Syndrome (ARDS). 
We focus on data from previously published clinical trials on 
the static and dynamic cardio-pulmonary responses of three 
ARDS patients to changes in ventilator settings. From this data, 
the parameters of the integrated model were identified using an 
optimization-based methodology in multiple stages. 
Computational simulations confirm that the resulting model 
outputs accurately reproduce the available clinical data. Our 
results open up the possibility of creating in silico a biobank of 
virtual ARDS patients that could be used to evaluate current, 
and investigate novel, therapeutic strategies. 
I. INTRODUCTION 
Computer simulation of critical illness and its treatment 
can offer an alternative perspective to that of traditional 
approaches employed in in vivo and in vitro trials. Complex 
system dynamics can be modelled and validated against 
patient-data, leading to the development of computational 
simulators that can be used as investigational surrogates. 
Simulation also offers the potential to “look inside” the 
patient - when models are accurately matched to patients, the 
non-measurable parameters within the patient can be 
estimated with confidence.  
Several examples exist in the literature detailing the 
development of models of cardiovascular and pulmonary 
systems for different applications [1]. With the exception of 
[2], few have discussed the difficulties that present 
themselves when integrating organ-level models of these two 
different systems. For the models used in this study, these 
difficulties included the different frequencies of the separate 
models (the cardiac model has a higher frequency), their 
different characteristics (the pulmonary model is primarily a 
gas flow model, whereas the cardiovascular model represents 
the flow of blood through the cardiovascular system), non-
linear cardio-pulmonary interactions etc. These issues, along 
with early work on the development of the integrated model 
(including innovative equations that were required to 
reproduce complex cardio-pulmonary interactions) were 
discussed in [3]. This follow-up paper focuses on the 
solutions of problems encountered with configuring the 
model parameters to represent the spectrum of dynamic 
responses associated with the integrated cardio-pulmonary 
pathophysiology of mechanically ventilated ARDS patients. 
Several previous studies have considered the task of 
patient specific model calibration (sometimes referred to as 
model configuration, parameter identification or parameter 
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estimation) in separate cardiovascular and pulmonary models 
[4-6]. Automated tuning of model parameters has been a 
common and reliable method [7, 8]. The conventional way to 
tackle problems involving large numbers of uncertain model 
parameters is to reduce the number of parameters involved in 
model calibration to those that are relevant to the available 
clinical data. This is done through a ‘sensitivity analysis’ 
whereby model outputs are assessed for changes in individual 
model parameters, with respect to the clinical data. The merit 
of this approach has been shown in previous modeling 
studies [7] and has been incorporated into the model 
calibration methodology. The complete model calibration 
algorithm is shown in Table I. 
The paper is organized as follows: Section II introduces 
the integrated cardio-pulmonary models and describes the 
model calibration methodology. Section III presents the 
results of the model calibration against static and dynamic 
data from individual ARDS patients. Section IV discusses the 
possible utilization and the limitations of the methodology, 
and offers some conclusions. 
II. METHODS 
A. Model Description 
Our study employs a highly integrated computer 
simulation model of the pulmonary and cardiovascular 
systems [3, 9]. The model includes 100 independently 
configurable alveolar compartments and 19 cardiovascular 
compartments. Aspects of the model related to pulmonary 
pathophysiology have been validated in a number of previous 
studies [10, 11]. The validated pulmonary model was 
integrated with a multi-compartmental, contractile 
cardiovascular model with pulsatile blood flow and 
ventilation-affected, trans-alveolar blood-flow. The cardiac 
section of the model consists of two contractile ventricles, 
with atria modeled as non-contractile, low-resistance, high-
compliance compartments (the atrial contribution to cardiac 
performance is lumped with the contractile ventricular 
model). Ventricular contractility is modeled as a truncated 
sine-wave that varies ventricular elastance over time. 
Cardiopulmonary interactions are modeled in a number of 
ways.  Intrapulmonary pressure is transmitted to the 
intraventricular, intrathoracic and intravascular 
compartments. Trans-alveolar blood flow is governed by 
driving (pulmonary artery) pressure, and by independent 
trans-alveolar vascular resistance; this resistance is affected 
dynamically in each alveolar compartment by alveolar 
volume (causing longitudinal stretch) and pressure (causing 
axial compression). Full details of the mathematical 
principles underpinning the model are available in [3, 12]. 
All model outputs presented here are averaged over 1 minute 
after a simulation time of 30 minutes. 
 
Creating Virtual ARDS Patients  
Anup Das1, Mainul Haque2, Marc Chikhani2, Wenfei Wang1, Jonathan G. Hardman2, Declan G. Bates1 
  
TABLE I.  ALGORITHM FOR FITTING MODEL OUTPUTS TO PATIENT 
DATA IN THE INTEGRATED MODEL 
1) Select model parameters for fitting. 
a) Select model parameters for the pulmonary model 
b) Select model parameters for the cardiovascular model 
through sensitivity analysis using Eq. (1). 
2)  Determine model parameters x for pulmonary model 
a) Use the pulmonary model, global optimization, and  
      Eq. (2) to determine parameter values (x) 
3)  Determine model parameters for cardiovascular model 
a) Use the integrated cardiopulmonary model, global  
               optimization, and Eq. (3), to determine parameter values  
              (u) that minimize E2 at different values of PEEP 
 
B. Selection of Patient Data 
Data regarding three ARDS patients was extracted from 
three papers from the literature, selected due to their 
inclusion of data on hemodynamic responses in ARDS 
patients to changes in mechanical ventilation, specifically 
changes in cardiac output to variation in positive end 
expiratory pressure (PEEP). The patients represent a cross 
section of ARDS patients, with varying severity (using the 
Berlin definition) and cardiac volemic status. General patient 
information is listed in Table II.  
The first patient dataset was taken from a paper published 
by Biondi et al [13]. Based on the data at PEEP = 0 cm H2O, 
the patient has a PF ratio of 150 mm Hg and cardiac output 
(CO) of 8 l min-1 (moderate ARDS with high CO). The 
second patient was taken from data published by Pinsky et al 
[14] and describes a patient with PF ratio of 167 mm Hg and 
cardiac output of 4.09 l min-1 (moderate ARDS with normal 
CO). The third patient dataset was taken from data published 
by Jardin et al [15] and describes a patient with PF ratio of 50 
mm Hg and cardiac output of 7.3 l min-1 (severe ARDS with 
high CO). 
TABLE II.  SETTINGS AT PEEP = 0 CM H2O OF THREE ARDS PATIENTS   
 
Moderate ARDS 
with high CO 
Moderate ARDS 
with normal CO 
Severe ARDS 
with high CO 
CO (l min-1) 8 4.09 7.3 
FIO2 0.5 0.45 1 
Vt (ml kg-1) 12 10 10 
PEEP (cm 
H2O) 
0 0 0 
 
C. Assignment of baseline model parameters 
To generate a general hemodynamic profile for a healthy 
subject, most values of resistances, unstressed volumes and 
pressures have been taken from standard data where 
available. The remaining model parameters were manually 
tuned to obtain model outputs within averaged population 
ranges as given in [16]. The model equations and healthy 
subject profile are described in detail in [3] and yield a 
baseline model with which to initiate the model calibration 
process.  
The pulmonary model has already been used to represent 
data on ARDS patients in [12]. Prior to the calibration of the 
cardiovascular model, a sensitivity analysis (SA) was 
performed. The aim was to determine key model parameters 
that are predominantly responsible for the model responses 
corresponding to clinical data, which involved calculating S 
below for each model parameter.  
        (1) 
Here, y is model outputs of CO and mean arterial pressure 
(MAP).  ymax, ymin and ybaseline are the maximum, minimum 
and baseline values of the model outputs calculated during 
the SA, respectively. A similar sensitivity analysis has earlier 
shown to be been useful in validating the pulmonary model 
[11]. The results of the sensitivity analysis indicate key 
parameters of cardiovascular model (in Table 3) in 
determining CO and MAP. The parameters are consistent 
with other cardiovascular modelling studies [7]. 
D. Model parameter configuration using optimization 
The model was configured to fit data from individual 
ARDS patients in two stages. In the first stage, the model was 
fitted to static data from separate patients (listed in Table 4). 
The data consisted of arterial and mixed venous blood gas 
values and cardiac output estimations for each patient, listing 
the following measurements at PEEP = 0 cm H2O: cardiac 
output in ml min-1 (CO), partial pressure of oxygen in arterial 
blood (PaO2), partial pressure of carbon dioxide in arterial 
blood (PaCO2), tidal volume (Vt) and fraction of oxygen 
inhaled air (FIO2). The model parameters (x) to be optimized 
for each of the 100 alveolar compartments were Pext, kstiff and 
TOP, representing the extrinsic pressure acting on an alveolar 
compartment, the stiffness of the compartment and the 
threshold opening pressure, respectively. The values for 
respiratory quotient (RQ), rate of breathing (VR), total 
oxygen consumption (VO2), and the inspiratory duty cycle 
were additional parameters determined by the optimization 
algorithm. In this case, the model-fitting problem was 
formulated to search for a configuration of model parameter 
values (x) that minimizes objective function E1 in the 
equation below:  
    (2) 
where y = [PaO2, PaCO2, TOPmean, Ppeak] are the model 
outputs and y’ = [PaO2’, PvCO2’, TOPmean’, Ppeak’] are the 
target values. PaO2’ and PaCO2’ are measurements obtained 
from the patient data. TOPmean is the average TOP of the 
alveolar units, which is set to 20 cmH2O [17]. Ppeak is the 
peak airway pressure which is minimized to 30 cm H2O (a 
target in the 2000 ARDSnet report [18]).  
Stage 2 of the fitting process required a search for the 
optimal values of the parameters of the cardiovascular 
models (u) effectively allowing the modification of the 
cardiovascular function. The optimization process was used 
to fit the data for changes in CO and mean arterial pressure 
(MAP) to changes in PEEP. For this stage, the optimization 
problem was formulated to find a configuration of model 
parameters (u) that minimizes the objective function E2:  
     (3) 
where 𝑦 yj = [COi, MAPj] are the model outputs and 
𝑦′y’= [COi’, MAPi’] are the CO and MAP values reported in 
  
the data for the jth PEEP value, with k different settings of 
PEEP. 
The optimization parameters (x) and (u) in stage 1 and 
stage 2, their sizes, ranges and units are summarized in Table 
3. Genetic algorithms (GA’s) were employed for the 
optimization processes of Stage 1 and 2, primarily due to 
their ease of application in problems with large and small 
parameter search spaces, and their capability to converge to 
the global optimum even in highly non-convex parameter 
spaces. Initial model calibration and analysis were performed 
on a 64-bit Intel Core i7 3.7 GHz PC, running Matlab 
(R2014a). Model calibration to data was performed using the 
‘Minerva’ high performance computing cluster provided by 
the University of Warwick (396 nodes, each with 2×hexa-
core 2.66 GHz 24 GB RAM) running Matlab (2015a) with 
global optimization and parallel computing toolboxes. 
TABLE III.  PARAMETERS FOR MODEL CALIBRATION 
 
Parameters Dimension Ranges Sensitivity  
x, model parameters used for 
optimization in Stage 1. 
VR (b 
min-1) 
1 
10 – 
20  
 
Duty 
Cycle 
1 
0.25 - 
0.5  
 
RQ 1 
0.7 - 
0.9  
 
VO2 (ml 
min-1) 
1 
250 – 
350  
 
TOP (cm 
H2O) 
100 5 - 70  
kstiff 100 -1 - 1  
Pext 100 
-30 – 
28.8 
 
Hb (g dl-
1) 
1 
90 – 
160  
 
  
u, model 
parameters 
used for 
optimization 
in Stage 2. 
Parameter 
suggested to 
be most 
sensitive 
from SA (S 
>5%) 
Plv, dias,c 
(mm hg) 
1 1-5  9% 
Prv,dysc,c 
(mm hg) 
1 1-5  38% 
λlv 1 1 - 15 25% 
λrv 1 1 - 15 27% 
λsa 1 1 - 15 15% 
λsv, 1 1 - 15 43% 
Rsv 1 
0.001 
- 0.05 
51% 
Rsa 1 
0.1 - 
0.20 
63% 
 npvr 1 0.5 - 2   
qpvr 1 
40 - 
80 
 
γpvr 1 0.8   
List of Abbreviations SA – sensitivity analysis, VR - Ventilator Rate, Duty Cycle - 
Inspiratory Time/Time for complete breath, RQ - Respiratory Quotient, VO2 - Oxygen 
Consumption, TOP - Threshold Opening Pressure, k - alveolar stiffness factor, Pext - 
Extrinsic pressure, Hb - Haemoglobin in blood, Plv,dias,c – Left Ventricle initial pressure, 
Prv,dys,c – Right Ventricle Pressure initial pressure,  λlv,- left ventricle elastance coefficient, 
λrv– right ventricular elastance coefficent, λsa – systemic artery elastance coefficent, λsv, 
systemic vein elastance coefficient, , Rsa - systemic venous resistance,  Rsa - systemic 
arterial resistance, pvr – pulmonary vascular resistance, npvr – pvr exponential coefficient, qpvr 
– alveolar volume pvr coefficeint, γpvr – thoracic pressure splinting coefficient. 
 
III. RESULTS 
Table 3 shows the results of the SA. Only parameters 
with S of > 5% are listed and selected for Stage 2. Table 4 
shows the results of Stage 1 of the model calibration process. 
The minimum value calculated for E1 was 0.3271 for the 
moderate ARDS high CO patient, 0.3716 for the moderate 
ARDS normal CO patient and 0.3823 for the severe ARDS 
high CO patient.  
Figure 1 displays the results of stage 2, where the model 
outputs were matched to increments in PEEP (given on the 
horizontal axes of Figure 1. The minimum value calculated 
for E2 was 0.1278 for the moderate ARDS high CO patient, 
0.0673 for the moderate ARDS normal CO patient and 
0.2172 for the severe ARDS high CO patient. 
TABLE IV.  RESULTS OF STAGE 1 OF MODEL CALIBRATION 
 
Moderate 
ARDS with 
high CO 
Moderate 
ARDS with 
normal CO 
Severe ARDS 
with high CO 
PaO2 (kPa) 11.2 (10.6) 10.8 (10) 7.5 (6.6) 
PaCO2 (kPa) 4.4 (5) 5.2 (5.3) 4.3 (3.7) 
PvO2 (kPa) 4.6 (NA) 4.4 (NA) 4.1 (NA) 
Shunt (%) 22 (NA) 16 (NA) 44 (NA) 
TOPmean (cm 
H2O) 
28 (NA) 20 (NA) 29 (NA) 
Ppeak (cm H2O) 32 (NA) 22 (NA) 30 (NA) 
The model outputs and (data) 
 
IV. DISCUSSION AND CONCLUSIONS 
The outputs of our calibrated model were consistently 
very close to the data derived from clinical trials, indicating 
acceptable validity of the suite of models in reproducing 
dynamic, in vitro, multi-organ behavior. Further simulations 
have also indicated that the integrated model is able to 
simulate and chart blood flow and pressure(s) accurately.  
The choice of Genetic Algorithms to perform the 
optimization was based on their inherent characteristics. 
Unlike local search algorithms, they are derivative free and 
less dependent on the initial parameter estimates. There are 
disadvantages to using GA’s, namely that global algorithms 
like GA’s typically require much longer computation times 
than local gradient-based methods. The algorithms have 
previously been compared in [11]. To speed up the 
optimization process, a parallelized computer code 
implementation of a genetic algorithm was employed in this 
study. Fortunately, the cost function evaluation process can 
be accelerated hugely by distributing the tasks to 
multiprocessors (multiple cores and/or multiple machines).  
High performance computing facilities available at the 
University of Warwick were configured and implemented to 
run the parallel computing processes. 
The capability of the integrated model to reproduce the 
detailed responses of individual ARDS patients opens up the 
possibility of rationally “designing” new multi-intervention 
treatment strategies in silico by exploiting the speed, 
reproducibility, and cost-effectiveness of “virtual” patient 
trials. In contrast to trials on both animal models and human 
patients, in silico models of individualized patient and disease 
pathology are completely configurable and reproducible – 
different treatments, or combinations of treatments, can be 
applied to the same spectrum of virtual patients, in order to 
understand their mode of action, quantitatively compare their 
effectiveness in multiple different scenarios, and optimize 
interventions for particular clinical objectives.  Seen from an 
  
engineering design perspective, such “virtual” trials using 
simulations that are rooted in real patient data can offer 
comparable (or sometimes greater) utility to that of clinical 
trial data. In particular, modelling studies provide 
unambiguous outcomes that allow future clinical trials to be 
honed and directed, massively accelerating the achievement 
of real changes in clinical practice 
The methodology has limitations. The small size of the 
clinical dataset considered to date does not yet allow for 
convincing statistical analyses. For simplicity, it is assumed 
that the parameters determining lung pathology remain 
unaltered after stage 1. We also assume that stage 2 
optimization parameters such as systemic arterial resistance, 
etc. do not vary with increases in PEEP. This could be 
improved by the implementation of different autonomic 
reflexes, which we aim to address in the near future. The 
sensitivity analysis was performed only locally around the 
parameter configuration of a baseline healthy subject. Ideally, 
global sensitivity analysis [7] would provide a better picture 
of the model parametric space. 
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